HCA Lifts Outlook as 3Q Profit, Revenue Rise
By Connor Hart
HCA Healthcare lifted its full-year outlook after logging higher profit and revenue in the third quarter, as same-facility admissions grew.
The Nashville, Tenn., hospital owner and operation said earnings are now on track to come in between $6.5 billion and $6.72 billion, or $27 to $28 a share. It had previously guided for a profit of $6.11 billion to $6.48 billion, or $25.50 to $27 a share.
The company now expects revenue of $75 billion to $76.5 billion, up from its prior outlook of $74 billion to $76 billion. Analysts polled by FactSet had forecast earnings of $26.33 on revenue of $75 billion.
The new outlook came as HCA posted a profit of $1.64 billion, or $6.96 a share, for its three months ended Sept. 30, compared with $1.27 billion, or $4.88 a share, in the same quarter a year earlier.
Stripping out one-time items, adjusted earnings were also $6.96 a share. Analysts were looking for $5.72 a share.
Revenue rose 9.6% to $19.16 billion, topping the $18.57 billion that Wall Street modeled.
Same-facility admissions increased 2.1% during the quarter. Chief Executive Sam Hazen said the company is continuing its work to increase access to healthcare, invest in advanced technologies and train its workers.
Shares rose 2% to $449.05 in premarket trading.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
October 24, 2025 07:48 ET (11:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for October
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
United States